菲利普莫里斯国际（PM.US）在巴克莱全球消费品会议上仅因汇率上调2026年报告EPS指引至7.28–7.43美元，调整后EPS区间8.35–8.50美元及其它假设维持7月22日口径不变

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549




FORM 8-K




CURRENT REPORT

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 8, 2026




Philip Morris International Inc.
(Exact name of registrant as specified in its charter)




Virginia 1-33708 13-3435103
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)




677 Washington Blvd,
Ste. 1100 Stamford Connecticut 06901
(Address of principal executive offices) (Zip Code)



Registrant's telephone number, including area code: (203) 905-2410

(Former name or former address, if changed since last report.)




Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Securities registered pursuant to Section 12(b) of the Act:


Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, no par value PM New York Stock Exchange
3.125% Notes due 2027 PM27 New York Stock Exchange
3.125% Notes due 2028 PM28 New York Stock Exchange
2.875% Notes due 2029 PM29 New York Stock Exchange
3.375% Notes due 2029 PM29A New York Stock Exchange
2.750% Notes due 2029 PM29D New York Stock Exchange
3.750% Notes due 2031 PM31B New York Stock Exchange
0.800% Notes due 2031 PM31 New York Stock Exchange
3.250% Notes due 2032 PM32 New York Stock Exchange
3.125% Notes due 2033 PM33 New York Stock Exchange
2.000% Notes due 2036 PM36 New York Stock Exchange
1.875% Notes due 2037 PM37A New York Stock Exchange
6.375% Notes due 2038 PM38 New York Stock Exchange
1.450% Notes due 2039 PM39 New York Stock Exchange
4.375% Notes due 2041 PM41 New York Stock Exchange
4.500% Notes due 2042 PM42 New York Stock Exchange
3.875% Notes due 2042 PM42A New York Stock Exchange
4.125% Notes due 2043 PM43 New York Stock Exchange
4.875% Notes due 2043 PM43A New York Stock Exchange
4.250% Notes due 2044 PM44 New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying ☐
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01. Regulation FD Disclosure.
On September 8, 2026, Philip Morris International Inc. (“PMI”) is hosting a live audio webcast of a presentation and question-and-answer session by Jacek
Olczak, Group CEO PMI, at the Barclays Global Consumer Conference. In connection with the webcast, PMI is furnishing to the Securities and Exchange
Commission the press release attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference into this Item 7.01.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed
“filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The
information in this Current Report on Form 8-K shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of
1933, as amended, except as may be expressly set forth by specific reference in such filing or document.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.


99.1 Philip Morris International Inc. Press Release, dated September 8, 2026 (furnished pursuant to Item 7.01).


104 Cover Page Interactive Data File (formatted in Inline XBRL).
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.




PHILIP MORRIS INTERNATIONAL INC.

By: /s/ DARLENE QUASHIE HENRY
Name: Darlene Quashie Henry
Title: Vice President, Associate General Counsel & Corporate
Secretary

Date: September 8, 2026
Exhibit 99.1




PRESS RELEASE

Investor Relations: Media:
Email: InvestorRelations@pmi.com Email: Corey.Henry@pmi.com
Stamford, CT: +1 (203) 905 2413 Stamford, CT: +1 (203) 905 2410
Lausanne: +41 582 424 500


Philip Morris International Participates in 2026 Barclays Global Consumer Conference;
Raises 2026 Full-Year Diluted EPS Forecast for Currency Only


STAMFORD, CT, September 8, 2026 – Philip Morris International Inc.’s (PMI) (NYSE: PM) Group CEO PMI, Jacek Olczak, will address
investors today at the 2026 Barclays Global Consumer Conference in Boston at 9:45 a.m. ET.

The live webcast will be available here. The webcast replay will be available at the same link for six months after the event. The webcast may
also be accessed on mobile devices by downloading PMI’s Investor Relations App at www.pmi.com/irapp.


2026 Full-Year Forecast

PMI raises its 2026 full-year reported diluted EPS forecast to a range of $7.28 to $7.43 to reflect currency only. Excluding a total 2026
adjustment of $1.07 per share, the forecast range for adjusted diluted EPS of $8.35 to $8.50 represents a projected increase of 10.7% to
12.7% versus $7.54 in 2025. Excluding a favorable currency impact, at prevailing exchange rates, of $0.24 per share (previously $0.15), this
represents growth of 7.5% to 9.5%. We also update our Q3 adjusted diluted EPS forecast for currency only to a range of $2.29 to $2.34, now
including an estimated 1 cent favorable currency impact (previously unfavorable 8 cents).

All other forecast assumptions remain unchanged from those communicated on July 22, 2026.

Factors described in the Forward-Looking and Cautionary Statements section of this release represent continuing risks to these projections.




1
Full-Year
2026
2025 Growth
Forecast
Reported Diluted EPS $7.28 - $7.43 $7.26
Adjustments
Amortization of intangibles 0.50 0.50
Fair value adjustment for equity investments 0.16 (0.18)
Restructuring charges 0.03 0.14
Income tax impact associated with Swedish Match AB financing 0.06 (0.25)
Non-cash impairment of RBH equity investment 0.33 —
Egypt sales tax settlement adjustment (0.01) —
Other 2025 Adjustments (1) — 0.07
Total Adjustments 1.07 0.28
Adjusted Diluted EPS $8.35 - $8.50 $7.54 10.7% - 12.7%
Less: Currency 0.24
Adjusted Diluted EPS, excluding currency $8.11 - $8.26 $7.54 7.5% - 9.5%
(1) Includes: $0.10 Germany excise tax classification litigation charge; ($0.10) RBH (Canada) Plan Implementation, including dividend income, net; $0.09 Impairment of
Wellness business related equity investment; $0.06 Loss on expected sale of consumer accessories and other businesses; $0.03 Impairment of goodwill; ($0.11) Tax items

Forward-Looking & Cautionary Statements

This press release contains projections of future results and goals and other forward-looking statements, including statements regarding
expected financial or operational performance; capital allocation plans; investment strategies; regulatory outcomes; market expectations;
business plans and strategies. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that
risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in
such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is
identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those
contained in any forward-looking statements made by PMI.
PMI's business risks include: marketing and regulatory restrictions that could reduce our competitiveness, disrupt our SFP commercialization
efforts, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; excise tax
increases and discriminatory tax structures; health concerns relating to the use of tobacco and other nicotine-containing products; litigation
related to tobacco and/or nicotine products and intellectual property rights; intense competition; inability to anticipate changes in adult
consumer preferences; use and reliance on third-parties; the adverse effects of global and individual country economic, regulatory and
political developments, natural disasters and conflicts; geopolitical instability; the impact and consequences of Russia's invasion of Ukraine;
changes in legal-age adult smoker behavior; continued decline of tax-paid cigarettes; lost revenues as a result of counterfeiting, contraband
and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, sustained
periods of elevated inflation, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; disruptions in
the credit markets or changes to its credit ratings; recent and potential future tariffs imposed by the U.S. and other countries; adverse
changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as product components for
its electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may
also be




2
adversely affected should it be unsuccessful, in key markets or systemically, in its efforts to introduce, commercialize, and grow smoke-free
products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new
products, and promote brand equity; if there are prolonged disruptions of facilities used to produce its products; if it is unable to enter new
markets or improve its margins through increased prices and productivity gains; if other market participants are more successful in their SFP
commercialization efforts; if it is unable to attract and retain the best global talent; or if it is unable to successfully integrate and realize the
expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our smoke-free
products performance.
PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for
the fourth quarter and year ended December 31, 2025, and the Quarterly Report on Form 10-Q for the second quarter ended June 30, 2026.
PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not
undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure
obligations.


Philip Morris International: A Global Smoke-Free Champion
Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its
portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily
consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are
available for sale in over 105 markets, and as of December 31, 2025, PMI estimates they were used by over 43 million legal-age consumers
around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business
accounted for approximately 42% of PMI’s second-quarter 2026 total net revenues. Since 2008, PMI has invested over $16 billion to develop,
scientifically substantiate and commercialize innovative smoke-free products for legal age adults who would otherwise smoke or use other
nicotine-containing consumer products, with the goal of completely ending the sale of cigarettes. This includes the building of world-class
scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-
market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish
Match’s General snus, ZYN nicotine pouches and versions of PMI’s IQOS devices and consumables - the first-ever such authorizations in
their respective categories. Versions of IQOS devices and consumables, General snus and 20 ZYN nicotine pouch variants also obtained the
first-ever Modified Risk Tobacco Product authorizations from the FDA in their respective categories. With a strong foundation and significant
expertise in life sciences, PMI has a long-term ambition to expand into wellness areas. References to “PMI”, “we”, “our” and “us” mean Philip
Morris International Inc., and its subsidiaries. For more information, please visit www.pmi.com and www.pmiscience.com.


Non-GAAP Measures, Glossary and Explanatory Notes

Reconciliations of non-GAAP measures in this release to the most directly comparable U.S. GAAP measures can be found in Exhibit 99.2 to
the Form 8-K dated July 22, 2026, and here. A glossary of key terms, definitions and explanatory notes is available in the aforementioned
Exhibit 99.2 and on the same webpage, where additional financial schedules, as well as adjustments and other calculations have also been
made available.
Management reviews earnings per share, or "EPS," on an adjusted basis, which may exclude the impact of currency and other items such as
acquisitions, divestitures, restructuring costs, tax items and other adjusting items. Additionally, starting in 2022 and on a comparative basis,
PMI includes adjustments to add back amortization expense on acquisition related intangible assets that are recorded as part of purchase
accounting and contribute to PMI’s revenue generation, as well as impairment of intangible assets, if any. While amortization




3
expense on acquisition related intangible assets is excluded, the net revenues generated from these acquired intangible assets are included
in the company's adjusted measures, unless otherwise stated. Currency-neutral rates reflect the way management views underlying
performance for these measures. PMI believes that such measures provide useful insight into underlying business trends and results.
Management reviews these measures because they exclude changes in currency exchange rates and other factors that may distort
underlying business trends, thereby improving the comparability of PMI’s business performance between reporting periods. Furthermore,
PMI uses several of these measures in its management compensation program to promote internal fairness and a disciplined assessment of
performance against company targets. PMI discloses these measures to enable investors to view the business through the eyes of
management.
Non-GAAP measures used in this release should neither be considered in isolation nor as a substitute for the financial measures prepared in
accordance with U.S. GAAP.



4